Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
IN8bio, Inc. (INAB) had Income from Continuous Operations of $-5.09M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-5.09M |
|
-- |
|
-- |
|
$5.27M |
|
$-5.27M |
|
$0.18M |
|
$-5.09M |
|
$-5.09M |
|
$-5.09M |
|
|
Income from Continuous Operations |
$-5.09M |
$-5.09M |
|
$-5.09M |
|
$-5.27M |
|
$-4.77M |
|
19.47M |
|
19.47M |
|
$-0.26 |
|
$-0.26 |
|
| Balance Sheet Financials | |
$22.66M |
|
$1.62M |
|
$3.60M |
|
$26.27M |
|
$2.16M |
|
-- |
|
$1.33M |
|
$3.48M |
|
$22.78M |
|
$22.78M |
|
$22.78M |
|
9.85M |
|
| Cash Flow Statement Financials | |
$-4.95M |
|
$-0.01M |
|
$-0.20M |
|
$27.31M |
|
$22.16M |
|
$-5.15M |
|
$0.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.50 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.96M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-22.34% |
|
-22.34% |
|
-19.38% |
|
-22.34% |
|
$2.31 |
|
$-0.25 |
|
$-0.25 |
|